The role of miRNA-576-3p in cisplatin sensitivity of ovarian cancer cells was reported by Zuo et al. In vitro studies using cisplatin-resistant ovarian cancer cell lines showed that miRNA-576-3p targets PD-L1 and cyclin D1. This evidence concerns the gene CCND1 and ovarian carcinoma.